CorMedix (CRMD) Misses Q4 EPS by 7c

CorMedix (NASDAQ: CRMD) reported Q4 EPS of ($0.26), $0.07 worse than the analyst estimate of ($0.19).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• TJX stock drops as profit outlook falls short of analyst estimates
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts